Optimal sequence of systemic therapy after sorafenib failure in patients with hepatocellular carcinoma

Sojung Han ,  Do Young Kim

Clinical and Molecular Hepatology

2020 .01

Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy

박정길

Clinical and Molecular Hepatology

2015 .01

Real-Life Experience of Sorafenib Treatment for Hepatocellular Carcinoma in Korea: From GIDEON Data

김도영 ,  김혜진 ,  한광협 외 13명

Cancer Research and Treatment

2016 .01

Sarcopenia with systemic inflammation can predict survival in patients with hepatocellular carcinoma undergoing curative resection

Ji Woong HWANG ,  Hanba ,  o KIM

Annals of Hepato-Biliary-Pancreatic Surgery

2022 .12

Effectiveness and safety of sorafenib 400 mg vs. 800 mg initial dose on survival in patients with advanced and intermediate stage hepatocellular carcinoma: A systematic review and meta-analysis

Roland HELMIZAR ,  Jufe ,  dy KURNIAWAN

Annals of Hepato-Biliary-Pancreatic Surgery

2022 .12

The clinical management of hepatocellular carcinoma in China: Progress and challenges

Shan Shan ,  Jidong Jia

Clinical and Molecular Hepatology

2023 .04

Tumor lysis syndrome following sorafenib treatment in hepatocellular carcinoma

Kim ,  Shin Young ,  Kim 외 7명

영남의대학술지

2015 .01

Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma

Sooyeon Oh ,  Jooho Lee

Clinical and Molecular Hepatology

2020 .01

Effect of autophagy modulation on sorafenib-induced cytotoxicity in hepatocellular carcinoma cells

Yeon Ju Jung ,  Jung A Hong ,  Inki Kim 외 1명

한국실험동물학회 학술발표대회 논문집

2019 .01

How long should physicians follow up with patients after curative treatment for hepatocellular carcinoma?

Bo Hyun Kim

Clinical and Molecular Hepatology

2020 .01

Systemic therapy in advanced hepatocellular carcinoma

Joseph C Ahn ,  Nguyen H. T ,  an 외 1명

Clinical and Molecular Hepatology

2023 .04

The emerging age-pattern changes of patients with hepatocellular carcinoma in Korea

Yu ,  i Cho ,  Bo Hyun Kim 외 2명

Clinical and Molecular Hepatology

2023 .01

Clinical usefulness of 18F-FDG PET in patients with hepatocellular carcinoma undergoing surgical resection

Min Ho SHIN ,  Nam Kyu CHOI

Annals of Hepato-Biliary-Pancreatic Surgery

2021 .12

Clinical usefulness of 18F-FDG PET in patients with hepatocellular carcinoma undergoing surgical resection

Nam Kyu CHOI

Annals of Hepato-Biliary-Pancreatic Surgery

2022 .12

An interim safety analysis of hepatocellular carcinoma patients administrating oral vitamin K with or without sorafenib

Dong-Hwan Jung ,  Shin Hwang ,  Gi-Won Song 외 4명

Annals of Hepato-Biliary-Pancreatic Surgery

2015 .02

Down-Regulation of TGF-β Expression Sensitizes the Resistance of Hepatocellular Carcinoma Cells to Sorafenib

Dongxu Kang ,  최혜진 ,  Zhezhu Han 외 3명

Yonsei Medical Journal

2017 .01

Effect of Introducing An Enhanced Recovery after Surgery Program for Patients Undergoing Resection of Hepatocellular Carcinoma

Masaki Kaibo ,  i

대한외과학회 학술대회 초록집

2019 .10

Effects of the mixed formulation of sorafenib and blue honeysuckle on the pharmacokinetics profiles of sorafenib

강현구 ,  강수진 ,  구세광 외 2명

대한예방한의학회지

2019 .01

The development of alcohol-associated hepatocellular carcinoma mouse model

Wonhyo Seo

한국실험동물학회 학술발표대회 논문집

2022 .07

Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma

Kim ,  Gwi Eon ,  Song 외 5명

Radiation oncology journal : ROJ

2017 .01